RPGR Validation of a Vision-Guided Mobility Assessment (VMA)
Research type
Research Study
Full title
A study in normally-sighted participants and in participants with RPGR associated X-linked Retinitis Pigmentosa (XLRP) to validate the Vision-Guided Mobility Assessment for use in natural history studies and therapeutic clinical trials of adult, adolescent and child patients with Inherited Retinal Diseases (IRDs).
IRAS ID
289223
Contact name
Michel Michaelides
Contact email
Sponsor organisation
MeiraGTx UK II ltd
Duration of Study in the UK
1 years, 1 months, 2 days
Research summary
This is a study in normally-sighted participants and in participants with X-linked Retinitis Pigmentosa (XLRP) associated with variants in the retinitis pigmentosa guanosine triphosphatase regulator (RPGR) gene (RPGR-XLRP) to validate the Vision-Guided Mobility Assessment commonly referred to as a maze. Validation of this assessment will allow for use in natural history studies and therapeutic clinical trials of adult, adolescent and child patients with Inherited Retinal Diseases (IRDs).
REC name
East Midlands - Derby Research Ethics Committee
REC reference
20/EM/0268
Date of REC Opinion
8 Dec 2020
REC opinion
Further Information Favourable Opinion